title: [Compliance of antiviral therapy and influencing factors in people living with HIV/AIDS in Nanjing].
abstract: OBJECTIVE
  To understand the compliance of highly active anti-retroviral therapy (HAART) and influencing factors in people living with HIV/AIDS (PLWHA) in Nanjing.
  
  
  METHODS
  PLWHA receiving HAART in No. 2 Hospital of Nanjing during May-June 2014 were recruited in this study. Self-administrated questionnaire was used to collect the data about HAART compliance and socio-demographic characteristics of PLWHA surveyed. Descriptive and multivariate statistical analysis were conducted to examine the effects of the factors on self-reported HAART adherence.
  
  
  RESULTS
  A total of 276 PLWHA were surveyed, According to the evaluation criterion of Center for Adherence Support Evaluation (CASE), 252 cases showed good compliance (91.3%). logistic regression analysis revealed that smoking, progress of the disease and side effects, reminding of taking drug and age were correlated with self-reported HAART adherence.
  
  
  CONCLUSIONS
  It is suggested to strengthen the education about antiviral therapy compliance in PLWHA with mild infection and those who are smokers and young, suffer from side effects, have no reminding methods for taking drug.
authors.affiliation: No. 2 Hospital of Nanjing, Nanjing 210003, China.
authors.forename: Hongxia
authors.initials: H
authors.lastname: Wei
authors.affiliation: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
authors.forename: Meng
authors.initials: M
authors.lastname: Li
authors.affiliation: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
authors.forename: Xiayan
authors.initials: X
authors.lastname: Zhang
authors.affiliation: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
authors.forename: Kai
authors.initials: K
authors.lastname: Bu
authors.affiliation: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
authors.forename: Yibing
authors.initials: Y
authors.lastname: Feng
authors.affiliation: Jiangsu Provincial Center for Disease Control and Prevention.
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Liu
authors.affiliation: Jiangsu Provincial Center for Disease Control and Prevention.
authors.forename: Ling'en
authors.initials: L
authors.lastname: Shi
authors.affiliation: Jiangsu Provincial Center for Disease Control and Prevention.
authors.forename: Yuheng
authors.initials: Y
authors.lastname: Chen
authors.affiliation: No. 2 Hospital of Nanjing, Nanjing 210003, China.
authors.forename: Chunqin
authors.initials: C
authors.lastname: Bai
authors.affiliation: Jiangsu Provincial Center for Disease Control and Prevention.
authors.forename: Gengfeng
authors.initials: G
authors.lastname: Fu
authors.affiliation: Jiangsu Provincial Center for Disease Control and Prevention; Email: huanxp@vip.sina.com.
authors.forename: Xiping
authors.initials: X
authors.lastname: Huan
authors.affiliation: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; Email: wanglu64@163.com.
authors.forename: Lu
authors.initials: L
authors.lastname: Wang
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000367:Age Factors; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002681:China; D018450:Disease Progression; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D017010:Reminder Systems; D012907:Smoking; D011795:Surveys and Questionnaires; D016903:Drug Monitoring
chemical_list: D000998:Antiviral Agents